The non-hospital-based point-of-care diagnostic products industry is expected to grow from US$ 12.9 billion in 2022 to US$ 33.6 billion by 2032, at a CAGR of 9.1 % during the forecast period. This growth is attributed to a number of factors, including the rising prevalence of chronic diseases, increasing demand for home healthcare, and technological …